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The  immune  response to poly (GluSaLys3SPhell)n  (GLq~la) 1 has been shown  to be 
under the control of two major histocompatibility complex (MHC)  - linked immune 
response (It)  genes at both the antibody and T-lymphocyte proliferative levels (1-3). 
The  two  genes  map  to  different  subregions  of I,  one  in  I-A,  the  other  in  I-E/I-C. 
Recently we  have  shown  that  antibodies directed against  Ia antigens coded  for by 
genes  in  either of the  two  subregions  could  inhibit  the  T-lymphocyte proliferative 
response to GI_~ (4). This result suggested that both Ir gene products were expressed 
at  the  cell  surface  (or  in  the  supernate  as  factors)  and  that  both  were  essential 
participants in this secondary response. In the present paper, we continue to explore 
the biological basis of Ir gene complementation by addressing the question of whether 
both gene products have to be expressed in the same or different cell types to generate 
an immune response to GI~. It will be demonstrated that both Ir gene products must 
be expressed in the same antigen-presenting ceil. 
Materials and  Methods 
Animals.  C57BL/10Sn(B10), B10.A/SgSn, B10.A(5R)/SgSn[5R], (B6A)F~, A/J, C57BL/6J, 
and  B I0.A(2R)/SgSn[2R] mice were purchased from The Jackson Laboratory, Bar Harbor, 
Maine.  B10.A(3R)/Sg[3R],  B10.A(18R)/Sg[18R]  and all F1 hybrids derived from these and 
the Jackson strains were bred in our own laboratories. Mice of both sexes were entered into the 
experiments between 8 and 20 wk of age. 
Antigens.  Two preparations of GL~ were utilized during the course of these studies. GL~ IJ 
was  the  generous  gift  of Dr.  Elkan  Blout,  Department  of Biological Chemistry,  Harvard 
Medical School, Boston, Mass. Poly (Glu~Lys35Pheg)n  (GI~  9) was purchased from Miles-Yeda, 
Rehovot,  Israel. Both  were  synthesized from  the  N-carboxyanhydrides of the  amino  acids, 
although the former was polymerized in benzene using sodium methoxide as an initiator, while 
* Supported in part by Public Health Service Research grant AI-06525. 
1  Abbreviations used in this paper: B, bone marrow-derived; CFA, complete Freund's adjuvant; DNA-OVA, 
dinitrophenyl conjugated ovalbumin;  EHAA, Eagle's-Hanks'-amino  acid medium; FCS, fetal calf serum; 
H-2, histoeompatibility 2 locus of the mouse; GL~, the terpolymer  of L-glutamic acid,  L-lysine and L- 
phenylalanine;  (H,G)-A--L, poly(His,Glu)-poly D,L-Ala--poly Lys; Ir, immune  response; MHC, major 
histocompatibility  complex; MLR, mixed lymphocyte reaction; PBS, phosphate-buffered saline; PETLES, 
peritoneal exudate T-lymphocyte-enriched subpopulation;  PPD, purified protein derivative of tuberculin; 
T, thymus-derived;  TEPC-15,  an IgA myeloma protein  with binding specificity for phosphorylcholine; 
(T,G)-A--L, poly(Tyr,Glu)-poly t),L-Ala--poly Lys; a, Ir-GIAb-a  gene; fl, lr-GL@fl gene 
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the latter was polymerized in dioxane using triethylamine as an initiator (5). Both polymers 
were dissolved in 1% Na2COs  in normal saline and immediately neutralized to pH 7.2 with 1 
N HCI. They were then diluted to 2 mg/ml with phosphate-buffered saline (PBS) and stored 
at -20°C. The branched chain synthetic copolymers, poly (Tyr,Glu)-polyD,L-Ala--poly  Lys 
[(T,G)-A--L]  (lot  no.  958  and  1383) and  poly  (His,Glu)-poly D,L-Aia--poly Lys  [(H,G)- 
A--L], were synthesized from the N-carboxyanhydrides as previously described (6) and were 
the generous gift of Dr. Edna Mozes,  the Weizmann Institute, Rehovot, Israel.  The polymers 
were dissolved in water, adjusted to 2 mg/ml with 10  X  PBS and stored at -20°C. The IgA 
myeloma protein, TEPC 15, was obtained from an ascites tumor (Litton Bionetics, Rockville, 
Md.)  and purified by affinity chromatography on a  phosphorylcholine column according to 
the procedure of Chesebro and Metzger (7). The p-nitrophenyl phosphorylcholine reagent was 
kindly provided by Dr.  H.  Metzger,  National Institutes of Health, Bethesda,  Md.  and the 
organic coupling reactions were performed with the help of Dr. J. K. Inman, National Institutes 
of Health. Pigeon cytochrome c was prepared from breast muscle according to the procedure of 
Brautigen et  al.  (8)  and  was  the  generous  gift  of Doctors  M.  Uhee  and  E.  Margoliash, 
Department of Biochemistry and Molecular Biology, Northwestern University, Evanston, Ill. It 
was  dissolved  directly in PBS  at  2  mg/ml and stored  at  -20°C.  In some experiments, T 
lymphocyte cultures from mice immunized with pigeon cytochrome c were stimulated with the 
cytochrome c from tobacco hornworm moth because the latter elicits a  heteroclitic response 
with a twofold higher maximum stimulation (A. Solinger, M. Ultee, E. Margoliash, and R. H. 
Schwartz,  unpublished observations).  Purif'md  protein  derivative of tuberculin (PPD)  was 
purchased from Connaught Medical Research Laboratory, Willowdale, Ontario, as a 2 mg/ml 
solution and stored at -20°C. The 2,4-dinitrophenyl derivative of ovalbumin (DNPT.5OVA) 
was prepared by reacting the protein (200 mg in 5 ml of borate buffer, pH 8) with fluorodini- 
trobenzene (10 #1) for 6 h and dialyzing against PBS. The conjugation ratio was determined by 
measuring the optical density at 360 nm. All antigens were diluted with culture medium to 
appropriate concentrations (20 #g/ml for PPD,  100-200  #g/ml for all the others)  just before 
use.  The  ability of the  various mouse strains used  in  this  study  to  mount T-lymphocyte 
proliferative responses  to each of these antigens is summarized in Table I. 
Immunizations.  Mice were immunized with 30 #g of DNP7.5OVA, 20-50 #g of GL~, 20-100 
#g of pigeon cytochrome c or 50 #g of (T,G)-A--L, (H,G)-A--L, and TEPC 15, emulsified 1  : 1 
in complete Freund's adjuvant containing 1 mg/ml of Mycobacterium tuberculosis, strain H37Ra 
(Difco Laboratories, Detroit, Mich.). g20th ml of emulsion was injected in either of the two hind 
footpads or in the base of the tail. When all five antigens were administered together, two were 
given in each footpad and one in the tail. 
Cell  Cultures.  The  preparation  of  peritoneal  exudate,  T-lymphocyte-enriched  cells 
(PETLES) and their in vitro culture with soluble antigen has been previously described (9-11). 
In one series of experiments the lymph node proliferation assay  of Corradin et al.  (12) was 
utilized except that 2  ×  105 cells were cultured in round bottom microtiter plates instead of 4 
×  105 cells in flat bottom plates.  The use of antigen-pulsed nonimmune  spleen cells to present 
antigen  to  immune  PETLES  has  recently  been  discussed  in  detail  (13).  In  the  present 
experiments, 1 X  107 spleen cells were exposed  to  100 #g of GI~ or 50 #g of PPD or DNP- 
OVA in the presence of 50 #g of mitomycin C in 1 ml of RPMI-1640 +  10% fetal calf serum 
(FCS)  for  1 h at 37°C. The cells were then washed five times with cold RPMI-1640 without 
FCS to remove unbound antigen and mitomycin C. Finally, the cells were counted, mixed with 
the immune PETLES or lymph node cells, and cultured for 5 days.  Stimulation was assessed 
by measuring the incorporation of a  1 #Ci pulse of (tritiated-methyl)-thymidine 16 h  before 
harvesting the cells. The data are expressed  as cpm  4-  the arithmetic standard error of the 
mean (SEM)  for triplicate or occasionally duplicate determiniations. 
Positive Selection of Antigen-Specific T-Cell Populations.  1 ×  105 PETLES from GI-~9-primed 
(B6A)F1 donors were cultured in the presence of I  ×  105 GLCp% or PPD-pulsed (B6A)F1 spleen 
cells in Eagle's Hanks' amino acid (EHAA) medium +  10% FCS for  10 days.  The remaining 
cells were  harvested, pooled, counted, and re.plated  in fresh  medium at  2  ×  104 cells per U 
bottom microtiter well. They were restimulated with 1 ×  l0  s fresh antigen-pulsed nonimmune 
spleen cells  for  3 days. Stimulation was  assessed  by measuring the incorporation of a  l  ~tCi 
pulse of thymidine added to the wells  16 h before the cells were harvested. 
Preparation of Bone Marrow, Radiation Chimeras.  F1 mice of both sexes, 10 wk or older, were 42  COMPLEMENTING  Ir  GENES  FUNCTION  IN  THE  SAME CELL 
TABLE  I 
Capability  of the B I O Congenic Strains  Utilized to Respond to the Antzgens Administered  in the Chimera 
Experiments* 
Ability to mount a T-lymphocyte proliferative response to 
Strain  Pigeon cy-  (H,G)-A--L  GLq~  DNP-OVA 
(T,G)-A--L  TEPC- 15  tochrome c  or PPD 
B10.A (or A/J)  -  +  +  +  -  + 
BI0 (or B6)  +  ....  + 
B 10.A(2R)  -  +  +  +  -  + 
B10.A(3R)  +  -  -  -  +  + 
BI0.A(5R)  +  -  -  -  +  + 
BI0.A(18R)  +  ....  + 
(BI0  ×  B10.A)FI  +  +  +  +  +  + 
(2R  x  BI0)F1  +  +  +  +  +  + 
(3R  x  B10.A)Fa  +  +  +  +  +  + 
(5R  x  B10.A)Fj  +  +  +  +  +  + 
(18R  ×  B10.A)FI  +  +  +  +  +  + 
* This data is a summary of experiments published in references  10,  I l, and  16 as well as unpublished 
observations of the authors. Plus indicates a responder, minus a nonresponder. 
lethally irradiated with 850-900  rads  (250  kV,  15  mamp dual X-ray source with 0.25 cm Cu 
and  0.55-cm  A1  filters;  dose rate  130  rads/min)  and  within  24  h  received an  intravenous 
injection of a  mixture of 5-7.5  ×  106  bone marrow cells from each parent according to the 
method of Von Boehmer et al.  (14).  Mice were treated intraperitoneally with 25  U  of heparin 
30 min before injection of cells. The bone marrow cells were obtained from male donors and 
pretreated  with  anti-Thy  1  (AKR  anti-0C3H)  serum  plus  guinea  pig  complement.  The 
effectiveness of the  anti-Thy  1  treatment  was  monitored  by  demonstrating that  the  small 
response of bone marrow cells to the T-cell mitogen, concanavalin A, was eliminated. Recipient 
mice were kept in laminar flow hoods and maintained on drinking water containing neomycin 
and  tetracycline  (Neo-Terramycin,  Pfizer  Inc.,  New  York;  1  teaspoon  per  liter  of water). 
Mortality varied with the strain combination but  was generally 60-70%.  Most of the deaths 
occurred during the first 2 wk after irradiation. The surviving mice were used between 2 mo 
and  1 yr after reconstitution. At sacrifice, spleen cells or PETLES  from the mice were typed 
with anti-H-2 sera to insure that  they were chimeras. An  (A/J  ×  B10.A)F1  anti-B10.A(5R) 
serum was used to detect cells bearing Kbl b and a  [B10.A(5R)  ×  A.BY]F1 anti-B10.A serum 
was  used  to  detect  cells bearing KaI a.  Both  sera  were  raised  by  multiple  injections of the 
appropriate spleen cells according to the method of David et al. (15). The assay was a two stage 
dye exclusion cytotoxicity one using rabbit complement screened for low background cytotox- 
icity (16).  The same sera were used for the mass kill experiments involving lymph node cells 
(Table III). In initial experiments, all mice were typed individually using spleen cells. After it 
became clear that every mouse tested was a balanced chimera (between 25 and 75% of the cells 
were of each  parental  type),  we  assayed  the  PETLES  to  be  sure  that  the  responding cell 
population was in  fact  chimeric. The data  are presented in  Table  II  as  the percent of cells 
expressing a  given histocompatibility type, which was calculated as follows: 
(live cells after antiserum treatment) 
1  -  ×  100. 
(live cells after normal mouse serum treatment) 
In the case of those experiments using spleen cells, the numbers presented represent the averages 
for all the mice used in the experiment. Generally three to five chimeras were pooled for each 
experiment. 
Results 
Radiation  Chimeras.  To address the question of whether separate cells, each express- 
ing one of the Ir-GLc~ genes, can collaborate and thus render an animal responsive to R.  H. SCHWARTZ, A.  YANO, J.  H. ST1MPFLING, AND W.  E.  PAUL  43 
GL~, radiation chimeras were created which allowed complementation at the cellular 
level but not the genomic level. Responder F1 hybrids, consisting of crosses between 
the  two  types of complementing GI_~ nonresponder  strains  (Ir-GL~-a+,fl -  and  Ir- 
GLdp-a-,fl+),  were lethally irradiated (850-900 rads) and reconstituted with a mixture 
of anti-Thy  1-treated bone marrow cells from both parental strains.  After 2-12 mo 
the chimeras were immunized and the PETLES proliferative response assayed. The 
basic conception  in  this  type of experiment  was that  if both  Ir-GLdp  gene products 
must be expressed in the same cell(s), then chimeras, which possess the Ir-GL~-a + and 
Ir-GL~-fl + genes in separate cells, should not respond to GI-zh. On the other hand, if 
the two gene products function in separate cells, which interact in the immune system 
to generate a  response (e.g.  T  cells and antigen-presenting cells),  then the chimeras 
should respond to GL~. The data are shown in Table II and Fig.  1. The experimental 
results for GL~ were unequivocal. In all chimeras composed of a mixture of parental 
cells  from  the  two  nonresponders  (2R  ~,  B10  and  18R  ~  B10.A)  there  was  no 
significant proliferative response to GLth. This suggests that complementation at the 
cellular level had not occurred. 
However,  proving  that  this  is  the  correct  interpretation  of the  negative  result 
required  a  large number of controls  which  were more difficult  to  firmly establish. 
First,  it  was  necessary  to  demonstrate  that  the  procedure  for  making  radiation 
chimeras did  not  produce  a  generally  hyporesponsive immune system which  could 
not  respond  to  GL~.  This  was  tested  by  transferring  bone  marrow  cells  from 
B10.A(5R)  or  (2R  ×  B10)F1  mice,  which  are  responders  to  GL~,  into  lethally 
irradiated  syngeneic  recipients.  As  shown  in  exp.  1-4  in  Table  II,  these  mice  all 
responded to GL~, and  in  most cases quite substantial  proliferative responses were 
observed. These mice also responded well to (T,G)-A--L and PPD. However, the Fa 
mice failed to give a proliferative response to the IgA myeloma protein, TEPC-15, an 
antigen to which the normal (2R  ×  B 10)F1 is capable of responding. The reasons for 
this  failure  to  respond  are  not  clear.  However,  it  should  be  pointed  out  that  the 
immunopotency of antigens such as TEPC-15,  (H,G)-A--L and pigeon cytochrome 
c  is  less  than  that  of GL~  or  (T,G)-A--L.  Thus,  when  the  chimeras  are  slightly 
hyporesponsive, this appears to be expressed in a failure to respond only to the weaker 
antigens and never to GI_zh. 
A  second  possible  cause  for  the  failure  to  respond  to  GI_~ was  an  unbalanced 
chimeric state, i.e.  the existence in the chimeras of lymphoid cells composed predom- 
inantly of one or the other parental cell  type.  H-2 typing of spleen or lymph node 
cells (Table II) revealed that every individual chimera derived 25% or more of its cells 
from each parental haplotype. The group averages for the three to five mice used in 
each  experiment  generally ranged  from 40  to  60%  for both  haplotypes  (Table II). 
This indicates the presence of lymphocytes of both parental types. However, the more 
difficult  question  to answer was whether  the cells in  the chimera were functionally 
balanced, i.e. were there cells of both parental haplotypes capable of proliferating by 
themselves in response to antigenic challenge. To test this, we immunized the chimeras 
with antigens, the response to which was controlled by Ir genes present in one, but not 
the other, parent (Table I). Thus, we evaluated the functional capacity of B10 and of 
18R cells by immunizing chimeras with (T,G)-A--L. B10 and  18R mice can respond 
to  this  antigen  but  B I0.A and  2R  mice  (their  respective partners  in  the  radiation 
chimeras) can not  (10).  As shown  in  Table II a  significant  proliferative response to 
(T,G)-A--L  in  PETLES  from  both  2R  ~  B10  or  18R  ~  B10.A  chimeras  was T
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Fro.  I.  The T-lymphocyte  proliferative response of PETLES from 3R ~  BI0.A  and 18R ~  B10.A 
chimeras. Chimeras were immunized 6 mo after irradiation and bone marrow reeonstitution. 3 wk 
later PETLES were harvested, and cultured at various cell numbers per well in the presence of 20 
/tg/ml of PPD  (O),  100/ag/ml of GL4}  9 (O),  1(30 #g/ml of (T,G)-A--L (ZX), 100 ~g/ml of pigeon 
cytochrome  c  (A)  or  only  medium.  Stimulation  was  assessed 5  days  later  by  measuring the 
incorporation of titriated-thymidine. The responses are expressed as the difference between cultures 
containing antigen and those with medium alone (LXcpm). Both the cells per well and the responses 
are presented as the actual numbers but plotted on a  log scale. 
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observed, indicating that the B 10 and  18R cells were functionally present. To test the 
functional capacity of B 10.A and 2R cells, the chimeras were immunized with (H,G)- 
A--L, TEPC-15 and/or pigeon cytochrome c.  B10.A and  2R  mice can  respond  to 
these antigens while B10 and  18R mice can not (10,  17). The reason for using a panel 
of antigens  to  test  responsiveness  in  this  case  was  because  of the  relatively  weak 
immunogenicity of each of them. This approach increased the probability of detecting 
at  least  one significant  proliferative  response  by cells  of the  B10.A or 2R  type.  As 
shown in Table II one of these three antigens did stimulate a significant proliferative 
response in all but one of the experiments, suggesting the presence of functional B 10.A 
and 2R cells. Despite this difficulty in uniformly eliciting B 10.A and 2R cell responses 
with all three antigens all of the time, we think the most striking aspect of the data is 
the failure to elicit any response in PETLES from these chimeras with the much more 
potent antigen, GLO. 
The data discussed so far strongly suggest that the chimeras possess functional cells 
of both parental  haplotypes.  However, one could now raise  the possibility that  the 
failure of these mice to respond to GI~ was caused by suppressive influences from a 46  COMPLEMENTING Ir GENES FUNCTION IN THE SAME CELL 
potential  mixed  lymphocyte reaction  occurring between  cells  of the  two  parental 
haplotypes. In setting up the chimeras, the bone marrow cells from both parents were 
treated with anti-Thy 1 serum plus complement to eliminate any mature T  cells  the 
population might contain. Although we attempted to document the complete elimi- 
nation of functional T  cells by demonstrating the disappearance of the small concan- 
avalin A  response of bone marrow cells,  and although Von Boehmer et al.  failed to 
find evidence of an  MLR  in  spleen  cells  from such  chimeras  (14),  the  findings  of 
Stutman (18) and of Gorczynski and Macrae (19) that there exists a rabbit anti-mouse 
brain resistant, postthymic T  cell in bone marrow, which quickly (I6 days) develops 
functional T-cell  properties  on transfer into  lethally  irradiated  recipients,  makes  it 
necessary to consider the possibility of a cryptic mixed lymphocyte reaction  (MLR). 
That  this  might  be a  serious  problem  in  some bone marrow,  radiation  chimeras is 
suggested in exp.  8 of Table  II. In this group of mice the spontaneous proliferative 
response of the  PETLES population  in  the  absence  of antigen  was  67,000  cpm, a 
value  never  seen  with  PETLES  from  normal  B10  or  B10.A  mice,  nor  from  most 
chimeras (Table II). Only two other chimera experiments showed a comparable result 
(data not shown) but in all cases there was little or no proliferative response detected 
over this high background to any antigen. Thus, the response to (T,G)-A--L, which 
in  all  the  other  chimera  experiments  was  significant,  either  did  not  occur or  was 
masked  by the  large  antigen-independent  proliferation.  Whether  this  spontaneous 
proliferation is actually an ongoing mixed lymphocyte reaction has not been formally 
tested. However, such data do raise this possibility and thus demand an experimental 
demonstration that, even in the case of low medium controls, the failure of chimeras 
to respond to GI_~ is not due to a suppressive MLR. 
To eliminate this possibility we created chimeras which have a similar potential for 
an MLR but in which one of the parental bone marrow donors is a responder to GL~. 
In this case, both/r-GL~ gene products would be expressed in a single cell(s),  unlike 
the previous chimeras. Therefore, these mice should respond to GI~, unless suppressed 
by  the  MLR.  The  chimeras  set  up  were  5R  ~  B10.A  and  3R  ~  B10.A.  These 
combinations maintain the potential K,I-A,I-B, and, in one case, the I-J incompati- 
bilities existing in the 2R ~  B10 and  18R ~  B10.A chimeras, thus keeping the major 
potential  MLR  stimulating  differences  (20).  The  only changes  in  the  two  sets  of 
chimeras lie in the I-E,I-C, S, and G regions which supply the 5R and 3R with the Ir- 
GL(p-a responder allele missing in the B 10 and  18R. Since these regions code for very 
weak MLR stimulating determinants  (20,  21), making the parental cells  compatible 
at  these  loci should not substantially  reduce the  total  MLR.  PETLES from 5R 
B10.A and 3R ~  B10.A chimeras immunized with GI~ gave a  substantial  prolifer- 
ative response to GL~, (exp.  12-I5 in Table II, and Fig.  1). The response of PETLES 
from these chimeras to GI~ was greater than responses to (T,G,)-A--L, TEPC-15 or 
pigeon cytochrome c. The striking difference between  the 3R ~  B10.A and  18R 
B 10.A chimeras is best seen in the dose-response curves shown in Fig.  1. These animals 
were  immunized at  the  same  time  and  assayed  2  days apart.  PETLES from both 
chimeras responded to the relatively weak antigen, pigeon cytochrome c, with a small 
but significant proliferative response.  In contrast, the 3R ~  B 10.A PETLES gave a 
strong proliferative  response  to GL~ while  the  18R ~-* B10.A  PETLES showed no 
response at all.  These results demonstrate that the existence in radiation chimeras of 
a potential suppressive MLR resulting from histoincompatibility at the K region and R.  H. SCHWARTZ, A.  YANO, J.  H.  STIMPFLING, AND W.  E.  PAUL  47 
the I-A,I-B,  and I-J subregions is not sufficient to account  for the failure of 18R 
B10.A and 2R *-~ B10 chimeras to respond to GL~. 
However, there still remained another possible reason why 2R ~  B10 and  18R 
B 10.A chimeras would not be capable of responding to GL~, while the 3R ~  B 10.A 
and 5R ~  B 10.A chimeras would respond. The in vitro proliferative response depends 
upon antigen-presentation by an adherent radioresistant cell (22-24).  When primed 
T  lymphocytes from normal (i.e. nonchimeric) T  lymphocytes are used, they can only 
be activated  by antigen  associated  with  cells  which  derive  from donors  possessing 
common alleles of genes encoded within the I-A subregion (13). In other assay systems, 
e.g. T-B collaboration (25) and expression of delayed-type hypersensitivity (26), it has 
been shown that chimeric cells can collaborate across such I-A  barriers.  However, if 
such  collaboration  were  not  possible  utilizing  our  assay  system  or  our  particular 
chimeras, then a-fl + ~  a+fl -  chimeras, such as the 2R ~  B10, might fail to respond 
to GI~ because the relevant cells could not collaborate with each other to generate a 
proliferative response to any antigen.  In other words,  the GL~ response of ot-fl  + 
a+fl -  chimeras would depend on collaboration across an I-A  barrier, while responses 
to other antigens (e.g. (T,G)-A--L) by these chimeras could be obtained by syngeneic 
collaboration.  In contrast,  the GL~ response of a+fl + ~  a-fl + chimeras, such as the 
5R ~  B10.A, does not have to result from collaboration across a  histocompatibility 
barrier as the responder a+fl + parental cells could  generate the GL~ response with 
syngeneic collaboration. Thus, to prove that the two Ir-GI_Ap  genes can not complement 
at  the  cellular  level,  it  was  essential  to  demonstrate  in  our  assay  system  that 
collaboration across an I-A  barrier could be achieved. 
To address this problem required  a  more complex protocol than that used in the 
previous  experiments.  Lymphoid cells  from chimeras  immunized  with  antigens  to 
which  both parents respond,  e.g.  DNP-OVA, have to be treated with anti-H-2 sera 
plus complement to eliminate cells of one or the other parental haplotype. One then 
has to show that  the remaining lymphoid cells respond to DNP-OVA presented on 
antigen-presenting  cells  from  the  opposite  parental  haplotype.  These  experiments 
proved technically  difficult  with  the  PETLES  assay system because of the low cell 
yield. However, this problem was overcome by turning to the lymph node proliferation 
assay  recently  described  by  Corradin  et  al.  (12).  5R  *-~  B10.A  chimeras  were 
immunized with DNPv.5-OVA and 8 days later the draining lymph nodes excised. A 
lymphoid cell suspension was prepared and treated with an (A/J  ×  B10.A)F1  anti- 
B10.A(5R)  serum  to  remove  the  BI0.A(5R)  parental  cells  and  leave  the  B10.A 
parental ceils, or treated with a  [BI0.A(5R)×A.BY]Fx  anti-B10.A serum to remove 
the  B10.A  parental  ceils  and  leave  the  B10.A(5R)  parental  cells.  The  remaining 
immune, parental-type lymphocytes were then challenged with DNPv.5-OVA-pulsed 
nonimmune  spleen  cells  from  either  parent.  As  shown  in  Table  III,  B10.A-type 
lymphoid cells obtained from the chimera were capable of proliferating in response to 
DNP-OVA bound to either B 10.A or B 10.A(5R) parental spleen cells. The magnitude 
of the response was similar for both presenting populations. The same was true for the 
B10.A(5R)-type  lymphoid  cells obtained  from the  chimeras  (exp.  2).  These  results 
demonstrate that the chimeric cells can collaborate with each other across a histocom- 
patibility  barrier to generate  a  proliferative response to  DNP-OVA.  Therefore, we 
feel confident in concluding that the failure of chimeras, composed of mixtures of the 
complementing nonresponder parental cells, to respond to GL~ cannot be the result 48  COMPLEMENTING  Ir GENES  FUNCTION IN THE  SAME  CELL 
TABLE  III 
Histoincompatible  Cells Maturing in a Chimeric Environment  Can Collaborate to Generate a Proliferative 
Response 
Exp.  Antiserum  Antigen-pulsed  Proliferative response (cpm +  SEM) to: 
spleen cells  Nonpulsed  DNP-OVA-pulsed 
1  Anti-KaI  a  B10.A  3,300 +  1,300  13,600 ±  2,400 
B10.A(5R)  3,000 ±  400  9,700 ±  3,000 
2  Anti-KaI  a  B10.A  1,800 +  500  6,300 ±  400 
B10.A(5R)  2,500 ±  800  7,700 ±  t,400 
Anti-KbI  b  BI0.A  2,300 ±  450  10,200 ±  3,200 
BI0.A(5R)  2,100 +  200  12,500 ::t: 2,700 
For each experiment three 5R ~  B10.A chimeras were immunized with 30/xg of DNPv.5OVA in CFA at 
the base of the tail, 8 days later the inguinal and periaortic lymph nodes were excised and the cells treated 
with either an (A/J  X  B10.A)Fa anti-B10.A (5R) serum (anti-KbI  h) or a [B10.A (5R)  ×  A.BY]Fj anti- 
BI0.A serum (anti-KaI  a) plus rabbit complement.  2 ×  10S-treated lymphoid cells were then cultured  in 
round bottom microtiter plates with 1 ×  l0  s mitomycin C inactivated, nonimmune spleen cells previously 
pulsed with 50 ~tg/ml DNPv,5OVA, or similarly handled nonpulsed spleen cells. Stimulation  was assessed 
5 days later by measuring  the incorporation  of tritiated thymidine using standard liquid  scintillation 
counting techniques. 
of a  general failure of cells from  the a-fl + donor  to collaborate with  cells from  the 
a+fl -  donor.  Rather,  it must  reflect a  need  for at  least one cell type involved in the 
proliferative response to GL~ to derive from an a+fl  + donor. 
Antigen-Presentation  of GL~.  Most proliferation assays appear to involve the inter- 
action  of at  least  two  cell types, one  a  primed,  antigen-specific, T-lymphocyte, the 
other a  nonimmune antigen-presenting cell (22, 23). In the mouse, the best sources of 
the latter cell type are PETLES  and spleen (13).  We have previously demonstrated 
for  antigen  responses  under  the  control  of  single  immune  response  genes  (e.g. 
poly[Glun°,Ala  a°,  Tyrl°]n),  that  the antigen-presenting cells must  be  derived from  a 
strain with a  responder haplotype to obtain a  proliferative response (27). In the case 
of (high responder  x  low responder)F1 PETLES, only spleen cells from the Fa or the 
high  responder  parent  could  present  antigen;  spleen  cells from  the  low  responder 
parent  were  ineffective.  These  results  suggested  that  Ir  gene  products  had  to  be 
expressed in antigen-presenting cells. 
The GI~  system represents a  more complex case. With two genes operating, it was 
possible that  only one  was  functioning  in  the antigen-presenting cell. The  chimera 
data argue that  at least one cell type must  express both gene products, but  this cell 
could  be  the  T-lymphocyte.  On  the  other  hand,  both  gene  products  might  be 
expressed in both cell types or, according to some models (28, 29), only in the antigen- 
presenting  cell.  To  investigate  the  /r  gene  requirements  for  antigen-presentation, 
complementing  (nonresponder  X  nonresponder)Fl mice were immunized with GL~ 
and  their  PETLES  stimulated  in  vitro  with  nonimmune,  GL~-pulsed  spleen  cells 
from F1 responders or from either type of parental nonresponder. The results from a 
typical experiment are shown  in Table IV (exp.  1).  PETLES  from  (B10.A  X  B10)F1 
mice  immunized  with  GL~  9  in  CFA  proliferated  in  vitro  when  stimulated  with 
nonimmune  (B10.A  ×  B10)F1 spleen cells that  had been pulsed with either GLq~ or 
PPD.  In  contrast,  GL~-pulsed  B10  and  B10.A  parental  spleen  cells did  not  elicit 
responses to GL~, although  these same parental spleen cells when  pulsed with  PPD 
could elicit significant PPD responses. The magnitude of the PPD response obtained R.  H.  SCHWARTZ,  A.  YANO, J.  H.  STIMPFLING,  AND  W.  E.  PAUL  49 
with either of the two PPD-pulsed parental spleen cell populations, although quite 
significant, was less than the response obtained with PPD-puised F1 spleen cells. Thus, 
one could argue that the failure of the parental spleen cells to present GI_~ was just 
an extreme form of the poorer presentation of all antigens to F1 PETLES by parental 
cells  as  compared  to  F:  spleen  cells.  However,  the  last  two  experimental  groups 
presented  in  each experiment  in Table IV  make  this  an  unlikely possibility.  First, 
mixtures of equal numbers of spleen cells from the B10 and B10.A parents did not 
present GI_~ any better than either parental cell type alone; whereas, in most cases, 
the  mixture  did  result  in  a  larger  proliferative  response  to  PPD.  Second,  when 
B10.A(5R)  spleen cells were used  for antigen  presentation, they presented GI~  as 
well as  the  (B10.A  ×  B10)F1 spleen cells, although their presentation of PPD was 
only as good as that of the B10 and B I0.A parental strains. B10.A(5R) is a responder 
to GI~, the haplotype being an intra-H-2 recombinant derived from the nonresponder 
B10 and B10.A parental strains in such a  way as to acquire the responder alleles at 
both  Ir-GL~  loci.  Thus,  possession  of both  Ir  gene  products  in  the  same  antigen- 
presenting cell is clearly required for the optimal presentation of GI~. 
In some experiments, (exp. 2, Table IV) the nonresponder parental spleen cells did 
stimulate  modest  proliferative responses  to  GL~,  although  never  as  great  as  the 
stimulation achieved with spleen cells from responder strains. We suspected that this 
low level of stimulation was caused by the transfer of antigen from the pulsed parental 
spleen cells to the residual antigen-presenting cells in the population of F1 PETLES 
used as a source of responding T  lymphocytes. To test this, however, we had to turn 
to  in  vitro-positive selection procedures.  In  this  technique,  PETLES from primed 
donors are cultured for 10 days in the presence of antigen bound to syngeneic spleen 
cells.  When the harvested cells are recultured in the presence of soluble antigen, no 
proliferative response is observed. However, if antigen-pulsed syngeneic spleen cells 
are added instead of soluble antigen, specific proliferation is seen. Thus, this tertiary 
proliferative  response  is  completely  dependent  on  the  addition  of fresh  antigen- 
presenting cells, presumably because antigen-presenting cells in the PETLES popu- 
lation are lost during the initial  10 day culture. Thus, problems of antigen transfer 
should be eliminated. When  PETLES from  (B6  ×  A/J)F1  mice primed to GI~ in 
CFA were selected with GL~-pulsed (B6A)Fa spleen cells, the recuhured cells gave a 
significant proliferative response when restimulated with Gl_~-pulsed (B6A)F: spleen 
cells but  no response at  all when stimulated  with GL~-pulsed B6 or A/J  parental 
spleen cells  (Table V).  In contrast, if the same  PETLES were selected with  PPD- 
pulsed (B6A)F1 spleen cells, then the recultured cells could be stimulated with either 
PPD-pulsed  (B6A)F:  cells  or  PPD-pulsed  spleen  cells  from  both  parental  strains. 
Mixtures  of the  two  parental  strains  did  not  produce a  response  to GI.~  in  GI~ 
selected cells, although it did increase the proliferation to PPD in PPD selected cells. 
These results indicate that it is essential to have both Ir-GL~ gene products expressed 
in the same antigen-presenting cell to stimulate a primed T-lymphocyte proliferative 
response to GL~. 
Discussion 
The discovery that  the immune response to several synthetic polypeptides (1,  30, 
31) and protein antigens (17,  32, 33) requires responder alleles at two distinct Ir loci, 
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We chose to work with the antigen GL~ because of the clear difference between the 
proliferative  responses  of responder  and  nonresponder  strains  (34).  If each  Ir  gene 
involved in  this immune response expressed its function  in  a  distinct  cell and these 
cells had to interact to generate an immune response, then cell mixing experiments 
should be able to demonstrate cooperative interactions between a-fl + and a+fl -  cells. 
To study such collaborations in the absence of alloreactions, bone marrow, radiation 
chimeras were established. In most cases a histocompatible environment was achieved 
(Table II). The results  clearly showed  that  chimeras composed of the  two types of 
nonresponder parental cells failed to mount an immune response to GL~. This failure 
to respond has also been observed in allophenic mice (35);  however, in those studies 
no rigorous attempt was made to rule out other explanations for the negative results. 
In our studies both parental cell types were shown to be present and to be biologically 
functional since the chimeras were capable of responding to the much weaker antigens, 
(T,G)-A--L, TEPC-15, pigeon cytochrome c and occasionally (H,G)-A--L. Further- 
more, the possibility of a  cryptic mixed lymphocyte reaction stemming from an H- 
2"/H-2  b  incompatibility  at  the  K  region  and  the  I-A  through  I-J  subregions  was 
eliminated  by  showing  that  the  3R  ~  B10.A  and  5R  ~  B10.A  chimeras  could 
respond to GI~. Finally the failure to cooperate was shown to be a unique property 
of complementing Ir gene systems in that cell cooperation across a potential histocom- 
patibility barrier could be demonstrated for the antigen, DNP-OVA. 
It should be pointed out that the recent studies of Zinkernagel et al.  (36,  37)  and 
Bevan  (38),  which  demonstrate  the  importance  of the  thymus  in  determining  the 
recognition  capabilities  of T  cells,  do  not  cloud  the  interpretation  of the  present 
chimera  experiments.  In  our  chimeras,  the  T  cells  mature  in  an  F1  thymus  and 
therefore should learn to recognize both H-2  ~ and H-2  b histocompatibility structures 
as well as any F1 specific structures that might be present on radioresistant cells. The 
failure  of such  chimeras  to  respond  to  GL4p is  consistent  with  and  represents  an 
extension of the recent observations of yon Boehmer et al.  (39)  on the transfer of/- 
region controlled  low responder parental  bone marrow cells into lethally irradiated 
(high responder ×  low responder)F1 recipients. These chimeras remained low respond- 
ers, suggesting a  requirement  for a  radiosensitive, high responder cell (or a  cell with 
a radiosensitive precursor) either in the peripheral lymphoid system or in the thymus 
of the chimera. In the case of the two gene GI~  system, it is the high responder Fx 
cells which are lacking. Moreover, the two gene system is actually a somewhat cleaner 
demonstration of this phenomenon in that parent ~  F1 chimeras often are not fully 
tolerant  to  the  opposite  parent  (40),  thus  leaving  any  results  obtained  with  such 
chimeras open to the possibility of aliogeneic effect artifacts. 
In the  second  series of experiments in  this  paper  (Tables IV and V), one of the 
critical  F1  cells  required  for  responsiveness  to  GLdp was  shown  to  be  the  antigen- 
presenting cell. Only spleen ceils from responder mice were capable of presenting GL~ 
to GLq-primed responder F1 cells.  Neither nonresponder parental spleen cell popu- 
lation was effective. In fact, mixtures of the a+fl -  and a-fl + parental cell types also 
failed to present GL~. This last experiment is formally analogous to the situation  in 
the  chimeras where  all  the  genetic  material  required  for an  immune  response was 
present  in  the system but was segregated into separate cells. The failure to achieve 
cooperation in both the chimeric and presentation experiments argues strongly that 
both Ir-GL~  gene products must be expressed in  the same antigen-presenting cell to 
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TABLe  IV 
Proliferative Response of GLdp Primed Fa Petles to GLdp and PPD Presented on Parental or F1 Spleen Cells 
Antigen-presenting*  Responder sta-  Proliferative  response (cpm  :1:  SEM) to spleen cells§ 
Exp.  nonimmune spleen  tus~ to GI-4b 
cells  Nonpulsed  GL~-pulsed  PPD-pulsed 
(B10.A  x  BI0)F~  High (a  +,/~+)  1,500 ±  300  18,100  ±  2,900  28,700  ±  500 
B10  Low (a-,/?  +)  !.,150 ±  300  2,500 -t- 500  13,400 +  800 
BIO.A  Low (a  +, fl-)  800  ±  200  2,200 :t: 200  9,600  +  900 
BIO +  BIO.A  Low +  low  1.,550 +  250  3,300 ±  850  20,000  ±  300 
B10.A(5R)  High (a+,/~ +)  600  ±  200  16,200  +  1,100  12,400  ±  950 
(B10.A x  BIO)F~  High (a  ÷, fl+)  1,300 :t:  500  20,400  +  1,200  30,700  ±  4,400 
B10  Low (a-,fl+)  1,600 ±  300  6,000  --. 900  17,600 ±  4,300 
B10.A  Low (0t  +, fl-)  1,100 ±  300  8,500  ±  2,200  19,900  ±  1,500 
BI0  +  BI0.A  Low  +  low  2,100 ±  500  5,600 +  700  23,900  ±  4,300 
B10.A(5R)  High (a ÷, fl+)  900  ±  200  20,700  +  3,000  19,800  :t:  1,500 
* 1 ×  l07 nonimmune spleen cells were pulsed with 20 pg/ml of PPD or 100/zg/ml  of GIz~  9 or GI~  n in 
the presence of 50 #g/ml of mitomycin C for 1 h at 37°C. The cells were washed five times and then used 
as a source of antigen-presenting  cells. 
~: Responder status refers to the ability of the spleen cell donors to mount an immune response to GL~. The 
letters in parentheses refer to the Ir-GLdp-a and -fl alleles possessed by these mice. 
§ 3 wk after immunization with 30 /.tg of GL~ in CFA, 1.5  ×  105 PETLES from (B10.A ×  BI0) mice were 
cultured in the presence of 1 ×  105 antigen-pulsed spleen cells for 5 days. Mixtures consisted of 1 ×  l0  s 
spleen cells of each type. Stimulation was measured as described in Table II. 
TABLE V 
Tertiary  Response of Positively  Selected (B6A)F1  T  Lymphocytes  to GLdp 
Parental or F1 Spleen Cells 
and PPD Presented on 
Selecting* 
antigen  Spleen cells 
Proliferative  response (cpm  +  SEM) to spleen cells* 
Nonpulsed  GLd?-pulsed  PPD-pulsed 
GL~ 
PPD 
(B6A)F~  2,400 +  300  11,000 ±  200  3,400 ±  160 
B6  1,100 ±  200  1,700 +  400  ND~ 
A/J  900  ±  150  1,600 +  20  ND 
1/2 B6  +  1/2 A/J  3,000 ±  50  3,100 =t=  500  ND 
(B6A)F~  4,500 ±  600  5,600 ±  400  11,800 ±  1,000 
B6  4,100 ±  250  ND  12,400 ±  1,600 
A/J  3,900 ±  900  ND  8,800  ±  1,100 
1/2 B6 +  1/2 A/J  6,400  ±  600  ND  19,100 ±  1,000 
* (B6A)F1 PETLES immune to GL~  s and  PPD were  cultured  for  10  days in  the presence of (B6A)FI 
nonimmune spleen  cells pulsed with either GL~  9 or PPD  (selecting antigen). The in  vitro  selected  T 
lymphocytes were then recultured at 2 ×  104 cells/well and stimulated for 3 days with t  ×  105 antigen- 
pulsed spleen cells from  (B6A)Fb B6 or A/J mice. Mixtures consisted of 5  ×  104 spleen cells from both 
parents. Cultures were pulsed with 1 ~Ci of tritiated thymidine on day 2 and the incorporation measured 
16-18 h later by standard liquid scintillation counting techniques. 
ND, not determined. 
This conclusion is  incompatible with the original  model proposed to explain two 
gene  complementation  in  the  immune  response  to  (T,G)-A--L  (31).  That  model 
suggested that  one  gene  product  was  expressed  in  T  lymphocytes, the  other  in  B 
lymphocytes (or alternatively in the antigen-presenting cell). Complementation  in the 
F1 involved the cooperation between the functional T  cell contributed by one parent 
and the functional B  cell contributed by the other parent. Both the chimera data and 
the  antigen-presentation data  presented  in  this  papr  indicate  that  this  is  not  the 
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to GI_~ as at least one of the cell types must express both gene products. The present 
data are also incompatible with a more recent two gene model proposed by Keck (41) 
in  which  each  Ir  gene  was  responsible  for  the  immune  response  to  a  separate 
determinant.  Recognition of either determinant  alone was insufficient  to generate a 
detectable  immune response;  but  the cooperative interaction  in  an  Fa  between  the 
two responding T  cells,  each still  recognizing  its own  determinant  on  the  antigen, 
would  lead  to a  strong  response.  Again,  one would  have expected  the  chimeras  to 
respond to GI_~ if such a  model were correct. Also recent experiments carried out by 
A. M. Solinger from our laboratory in collaboration with M. Ultee and E. Margoliash 
at Northwestern University, Evanston, Ill., have demonstrated that the dual Ir gene- 
controlled proliferative response to pigeon cytochrome c in B 10.A  mice involves the 
recognition of a  single antigenic determinant  and  not  two separate determinants as 
would be predicted by the Keck model. 
The requirement for both gene products to be expressed in a single cell would thus 
seem to necessitate that  any mode] for Ir gene complementation postulate an inter- 
action  at  the molecular level. This could occur in  a  number of ways.  In the model 
proposed by Warner et al.  (35),  the Ir-GL~-a product  is postulated  to allow the/r- 
GLdp-fl gene  product  to  be  externalized,  presumably  by  some  sort  of  enzymatic 
modification  or  biologic  transport  mechanism.  This  idea  is  compatible  with  the 
present  data;  however,  it  is  not  readily  compatible  with  our previously published 
observations  that  the  proliferative  response  to  GL~ could  be blocked  with  anti-Ia 
antisera directed  against  products of the I-E/I-C subregion,  which  codes for the/r- 
GL¢o-a gene (4).  This result suggested that the Ir-GL~-a gene product is expressed on 
the cell surface and that  its function can be inhibited  there.  In its simplest form the 
Warner model predicts that, if expressed on the surface at all  (e.g.  in transport), the 
Ir-GL~p-a gene product's function would have been completed before the in vitro test 
and, therefore, no inhibition should have occurred. 
The model which we currently favor is based on the conclusion from the blocking 
studies that both Ir-GL(p gene products are expressed on the cell surface and function 
there.  We  would  postulate  that  the  /-region  products  exist  on  the  surface  of the 
antigen-presenting cell, where they are present as dimers or tetramers of the original 
gene products./-A  and/-E/I-C gene products would be structurally equivalent and, 
therefore, hybrid molecules would exist containing elements of both gene products. If 
the immune response to GL~ could only occur via these hybrid molecules, then they 
would  constitute  the  unique  F1  intermolecular  structures  required  by  the  results 
presented  in this paper. As shown in Fig.  2,  the mechanism by which  they function 
could involve either dual  recognition or associative-recognition type models  (24,  28, 
42-45)  although the latter is somewhat simpler to reconcile with the two gene model 
(for a  discussion of this point see reference 24).  Support  for such an /-region hybrid 
product model is provided by the recent  work of Fathman and  Nabholz  (46).  They 
demonstrated that in an A/J anti-(B6A)Fa mixed lymphocyte reaction, some respond- 
ing T  lymphocytes were specific for F1 determinants.  Mapping studies suggested that 
at least two and possibly more/-region gene products were required to form these F1 
stimulating  determinants  on  the  cell  surface.  Thus,  the  requirement  that  GLCp be 
recognized in association with such F1 structures seems to us only a  logical extension 
of this biological situation. 
Very recently,  a  variation  on  our model  has been  suggested  by Jones et  al.  (47) R.  H.  SCHWARTZ,  A.  YANO, j.  H.  STIMPFLING,  AND  W.  E.  PAUL 
1. Complex Antigenic Determinant Hypothesis 
2. Dual Receptor Hypothesis 
Fxo.  2.  A schematic representation of the two types of hybrid molecule models for the antigen- 
presenting cell,  T-cell  interaction  in  the  immune  response  to  GI~.  In  the  complex  antigenic 
determinant model the GI~ associates with the Frspecific I region product (A/C) on the surface of 
the antigen-presenting cell and is recognized by a  single receptor on the T  cell with specificity for 
both the antigen and the I region product. In the dual recognition model, GI~ and the unique FI 
I region product are recognized by two separate T-cell receptors. 
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based on the biochemical characterization of unique Ia-bearing molecules found only 
in  certain  F1  hybrids  and  recombinants  and  not  in  the  parental  haplotypes  from 
which they were derived. These molecules appeared to contain Ia specificities coded 
for by the I-E/I-C  subregion but  in  addition  contained  some product(s)  of the I,A 
subregion.  Such  potential  chain  mixtures  of Ia-bearing components could  explain 
most of the GI-4, results,  if recognition  and response to GLdp required  these unique 
hybrid molecules. It could even explain the phenomenon offl-fl complementation (2), 
if unique I-A, I-A  hybrid molecules could also be found. However, certain aspects of 
the blocking studies are difficult to reconcile with such a model. In this case blocking 
with  antisera  directed  against  the  I-A  subregion  products  might  not  be  expected, 
because such antisera failed to precipitate the unique hybrid molecules described by 
Jones et al.  (47).  On the other hand, her studies were conducted with anti-/-A k and 
I,A b sera  whereas  ours were  done  with  anti-i,A d  sera.  Furthermore,  we  found  the 
blocking of the proliferative response to GI~ with anti-/-A d sera quite difficult in that 
only a  few sera out of many tested worked, and adsorption  to remove the anti-i,A d 
antibodies from those sera only partially eliminated  the blocking activity (4).  Thus, 
further studies are required to definitely decide whether the Fa hybrid molecules are 
formed in the cytoplasm as suggested by Jones et al. (47)  or on the cell surface as we 
have suggested (Fig. 2). 
Summary 
The  immune  response  (h)  to  the  random  copolymer  GL~  depends  upon  the 
function of two/r genes, Ir-GLdp-fl[fl]  and h-GL¢p-a[a],  mapped to the I-A  and I-E/C 
subregions of the major histocompatibility complex, respectively. In this paper, the 54  COMPLEMENTING Ir GENES FUNCTION IN THE SAME CELL 
site(s)  of expression of the products of these two Ir genes was examined by evaluating 
T-lymphocyte proliferative  responses of bone marrow radiation  chimeras.  Chimeras 
were created  in  [a+fl  -  ×  a-fl+]F1 responder mice by lethal  irradiation  and reconsti- 
tution with a mixture of bone marrow cells from both parental strains. These chimeras 
failed  to  respond  to  GI-4,  although  they  were  capable  of responding  to  the  much 
weaker antigens, (T,G)-A--L, TEPC-15, pigeon cytochrome c, and (H,G)-A--L. This 
failure to respond to GI.4b was shown not to be the result of a cryptic mixed lymphocyte 
reaction,  as  similar  chimeras  created  in  (a+fl +  ×  a-fl+)F1  mice  responded  well  to 
GI.d,  ,  although  they  possessed  almost  the  same  potential  histoincompatibility.  Fur- 
thermore,  the lack of response to GI-4b could not be attributed  to a  general  failure of 
the  two  parental  cell  types  in  the  chimeras  to collaborate  with  each other,  as each 
chimeric  parental  cell  type  could  respond  to  dinitrophenyl  conjugated  ovalbumin 
presented on nonimmune spleen cells from the other parent.  Thus, the failure of low 
responder parental  into F1 high responder chimeras to generate an immune response 
to GI_4b suggests that  immune competence  for this  antigen  requires  at  least  one cell 
type  in  the  immune  system  to express  gene  products  of both  the  Ir-GLeo-a  and  -t3 
genes, i.e.  one cell must be of high responder genotype. 
That the antigen-presenting cell is one such cell type was shown by experiments in 
which  GL~-primed  T  lymphocytes  from  responder  F1  mice  were  stimulated  with 
antigen  bound  to nonimmune spleen  cells.  Only spleen  ceils  from responder  F1 and 
recombinant  mice  could  present  GL~.  Neither  of the  two  complementing  nonre- 
sponder parental spleen cell populations, either alone or mixed together, could present 
GI~, although both could present  purified protein derivative of tuberculin.  This was 
shown to be the case for T  cells positively selected in vitro as well as freshly explanted 
T  cells.  Thus,  both  Ir-GLdo-a  and  Ir-GLq~-fl  gene products must  be expressed  in  the 
same  antigen-presenting  cell  to  generate  a  T-lymphocyte  proliferative  response  to 
GIAb. The implications of these findings for models of two gene complementation are 
discussed. 
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